Related Experiment Videos
Management of complicated preeclampsia
1Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston 77555-0587, USA.
Seminars in Perinatology
|April 2, 1999
Summary
This review discusses evolving treatment strategies for severe preeclampsia, a condition posing significant risks to both mothers and newborns. It covers expectant management, anesthesia, delivery, and new pharmacological and interventional approaches.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Critical Care Medicine
Background:
- Preeclampsia presents complex challenges in antepartum and postpartum care.
- Severe preeclampsia is a major contributor to maternal and perinatal morbidity and mortality.
- Current treatment paradigms require continuous evaluation and updates.
Purpose of the Study:
- To review developing trends in the management of severe preeclampsia.
- To outline new concepts in treating cerebrovascular complications and hepatic rupture associated with preeclampsia.
- To provide an updated perspective on clinical and pharmacological interventions.
Main Methods:
- Literature review of current and emerging treatment strategies for severe preeclampsia.
- Analysis of trends in expectant management, anesthesia, and delivery route selection.
- Examination of novel pharmacological approaches and interventions for specific preeclamptic complications.
Main Results:
- Expectant management strategies for patients remote from term are evolving.
- Anesthesia and delivery route choices are critical in managing severe preeclampsia.
- New pharmacological agents and treatment concepts for cerebrovascular events and hepatic rupture show promise.
Conclusions:
- The management of severe preeclampsia requires a multifaceted approach, integrating updated clinical practices.
- Continuous research into novel treatments is essential to reduce maternal and perinatal complications.
- Clinicians must stay abreast of developing trends to optimize care for preeclamptic patients.